Advertisement

Topics

Search Results for "Infusion Therapy Home Infusion Companies"

13:07 EST 8th December 2016 | BioPortfolio

Matching Channels

Intraosseous Infusion

CD20 Antibodies

The chimeric anti-CD20 antibody rituximab (Rituxan & MabThera) from Biogen Idec and Genentech/Roche is one of the world’s commercially most successful antibodies (2007 sales of over US$ 5 bl...

Lysosomal storage disorders (LSDs)

Lysosomal storage disorders (LSDs) represent a group of about 50 genetic disorders caused by deficiencies of lysosomal proteins. Most involve genetic mutations causing loss of function of key catabo...

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

California

In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Matching News

Diplomat unifies infusion companies under new Diplomat Specialty Infusion Group

David SalazarThe brand unites American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx and XAS infusion services under Diplomat Specialty Infusion Group.  read more

Five Key Takeaways from the New 2016 Infusion Therapy Standards of Practice

Earlier this year, one of the most widely used resources guiding clinical practice for the infusion specialty received a major upgrade. The Infusion Nurses Society (INS) issued a revised Infusion Ther...

BD receives funding for insulin infusion therapy improvements

BD will be entering into a new research partnership with JDRF to improve insulin infusion sets, according to a company press release. “Insulin infusion therapy has substantial clinical benefits for ...

ICU Medical to acquire the Hospira Infusion Systems Business from Pfizer for $1B

ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. The Hospira Infusion Systems business includes IV pumps, ...

Home infusion patient satisfaction to be studied

Following through on an initiative announced at its 2016 annual meeting (New Orleans, March 21-24), the National Home Infusion Foundation has launched a “patient satisfaction survey” study. Th...

ICU Medical buys Hospira's infusion therapy business from Pfizer

Seeking to become a leading global pure play infusion therapy firm, ICU Medical Inc. is paying $1bn--$400mm in its stock and $600mm in cash--to acquire Pfizer Inc.’s Hospira Infusion Systems busines...

ICU Medical to buy Pfizer's infusion therapy business for $1 bln

Oct 6 (Reuters) - Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock.

Pfizer sells off global infusion unit to ICU for $1 billion

Pfizer's is selling its global infusion therapy business, Hospira Infusion Systems, to ICU Medical, in a cash/stock deal worth $1 billion.

Matching PubMed Articles

The 2016 Infusion Therapy Standards of Practice.

Approximately every 5 years, the Infusion Nurses Society publishes evidence-based practice standards. This article provides an overview of the process used in standards development, describes the form...

The Role of Unlicensed Assistive Personnel in the Provision of Infusion Therapy.

Infusion Standards: A Document Without Borders.

The 2016 Infusion Therapy Standards of Practice.

Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease.

The introduction of a home therapy option during clinical trials of velaglucerase alfa in patients with type 1 Gaucher disease marked the first time that home infusions have been permitted during a cl...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement